CBE ID
0222
1.4 Project
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description
Percentage of women with Stage I-IIb breast cancer that received either axillary node dissection or Sentinel Lymph Node Biopsy (SLNB) at the time of surgery (lumpectomy or mastectomy)
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Number of women in the denominator that received either axillary node dissection or SLNB at the time of surgical resection of the primary tumor.
-
1.15 Denominator
Number of women with diagnosis of stage I-IIb breast cancer that received either lumpectomy or mastectomy
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Cancer Endorsement Maintenance ProjectInitial EndorsementLast UpdatedRemoval Date
-
StewardIntermountain HealthcareSteward Organization POC Email
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-